Itopride
Therapeutic agent (verify pharmacological class)
What it is used for
GI symptoms caused by reduced GI motility. Clinical selection for Itopride should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Allergy to the drug or any of its ingredient; Parkinsonism; young patients; concomitant use with medicines that cause extrapyramidal side; effects; prolonged therapy; those at risk of fluid retention; renal impairment; elderly; GI obstruction or bleeding.
Possible side effects
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.